Spearhead the imaging biomarker strategy and implementation across cardiovascular and metabolic indications in early- and late-phase clinical trials.
Base: $176,100.00 - $287,300.00; Bonus/Equity: annual bonuses, equity awards; Benefits: comprehensive benefits
Must-have
Nice-to-have
Not specified